Olema Pharmaceuticals, Inc.

NasdaqGS:OLMA 주식 보고서

시가총액: US$502.7m

Olema Pharmaceuticals 미래 성장

Future 기준 확인 0/6

Olema Pharmaceuticals 의 수익은 연간 4.1% 감소할 것으로 예상되는 반면, 연간 수익은 77% 로 증가할 것으로 예상됩니다. 77% 연간. EPS는 연간 4.1% 만큼 쇠퇴할 것으로 예상됩니다. 자기자본이익률은 3년 후 -66.1% 로 예상됩니다.

주요 정보

-4.1%

수익 성장률

-4.1%

EPS 성장률

Biotechs 수익 성장28.3%
매출 성장률77.0%
향후 자기자본 수익률-66.1%
애널리스트 커버리지

Low

마지막 업데이트20 Nov 2024

최근 미래 성장 업데이트

Recent updates

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Aug 29
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Olema Pharmaceuticals: Still Merits A Small Holding

Jun 17

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

May 11
Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

Palazestrant's Journey: Olema Pharmaceuticals' Long Oncology Path

Mar 28

Estimating The Fair Value Of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Mar 04
Estimating The Fair Value Of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

Nov 09
Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

We're Keeping An Eye On Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Jun 11
We're Keeping An Eye On Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Will Olema Pharmaceuticals (NASDAQ:OLMA) Spend Its Cash Wisely?

Mar 01
Will Olema Pharmaceuticals (NASDAQ:OLMA) Spend Its Cash Wisely?

Olema Oncology grants stock options for 58.3K shares

Oct 05

We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Sep 13
We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Olema Pharmaceuticals GAAP EPS of -$0.82 misses by $0.18

Aug 09

Olema stock soars 12% as FDA grants fast track status to OP-1250 for breast cancer subtype

Jul 21

We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Easily Afford To Drive Business Growth

May 29
We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Easily Afford To Drive Business Growth

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Feb 08
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Our Take On Olema Pharmaceuticals

Jan 05

We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Sep 19
We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Afford To Drive Business Growth

Jun 04
We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Afford To Drive Business Growth

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Feb 19
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

수익 및 매출 성장 예측

NasdaqGS:OLMA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20268-182-166N/A3
12/31/2025N/A-162-145-1375
12/31/2024N/A-133-108-785
9/30/2024N/A-123-97-97N/A
6/30/2024N/A-110-92-92N/A
3/31/2024N/A-99-87-87N/A
12/31/2023N/A-97-84-84N/A
9/30/2023N/A-96-85-85N/A
6/30/2023N/A-97-81-80N/A
3/31/2023N/A-110-85-85N/A
12/31/2022N/A-105-82-82N/A
9/30/2022N/A-100-82-81N/A
6/30/2022N/A-95-76-75N/A
3/31/2022N/A-79-59-58N/A
12/31/2021N/A-71-52-51N/A
9/30/2021N/A-60-42-41N/A
6/30/2021N/A-52-37-37N/A
3/31/2021N/A-38-29-29N/A
12/31/2020N/A-24-20-20N/A
9/30/2020N/A-15-12-12N/A
12/31/2019N/A-4-3-3N/A

애널리스트 미래 성장 예측

수입 대 저축률: OLMA 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: OLMA 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: OLMA 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: OLMA 은(는) 내년에 수익이 없을 것으로 예상됩니다.

고성장 수익: OLMA 은(는) 내년에 수익이 없을 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: OLMA (는) 3년 내에 수익성이 없을 것으로 예상됩니다.


성장 기업 발견